<DOC>
	<DOCNO>NCT01815762</DOCNO>
	<brief_summary>Patients select Dialisys Centers Iasi , Romania . Patients randomize 1:1 dry-weight assessment base clinical ( control ) lung US bioimpedance ( active ) guide protocol . In control group post-dialysis dry weight adjust base clinical criterion ( blood pressure , presence edema , intradialytic hypotension , cramp etc . ) active group target weight prescribed use lung US bioimpedance evaluation . In patient randomize active arm study , US B-line score ( BLS ) measure dialysis measurement use titrate ultrafiltration prescription . In patient present moderate severe lung congestion ( ≥15 BLS pre-dialysis ) LUS measurement repeat week treatment goal achieve ( &lt; 15 BLS pre-dialysis ) month thereafter . The ( monthly ) monitoring frequency adopt also patient without pulmonary congestion pre-dialysis baseline ( &lt; 15 BLS ) . Furthermore , use technique allow whenever application deem useful assume clinical decision attend physician . Patients active arm study without evidence lung congestion baseline develop pulmonary congestion ( ≥ 15 BLS ) trial receive treatment contemplate lung congestion baseline trial . The treatment goal pursue ultrafiltration intensification realize within HD schedule ( 3 session x 4 hours/week ) , tolerate , extra-dialyses , accord individual tolerance feasibility . In case clinical hypovolemia ( persistent cramp , hypotension etc ) additional dry-weight adjustment perform accord bioimpedance measurement , provide patient 15 BLS . This addition necessary order able increase dry-weight patient persistent BLS &lt; 15 avoid perfusion . Patients control arm study follow manage strictly standard criterion accord current recommendation ( imply optimization fluid volume control basis clinical criterion use carvedilol , ACE inhibitors/sartans whenever deemed necessary ) ; use lung US / bioimpedanc assistance messured patient . The main exclusion criterion presence severe cardiac failure ( NYHA class III-IV ) , past myocardial infarction , stable unstable angina acute coronary syndrome . Due bioimpedance assessment limitation patient metallic joint prosthesis , cardiac stent pacemaker , decompensated cirrhosis , pregnancy limb amputation exclude , BIS accurately perform case . Due lung US measurement limitation exclude patient know persistent pleurisy , pulmonary fibrosis pneumectomy . Other exclusion criterion malignancy , active infection , temporary permanent catheter vascular access , mental incompetence unwillingness participate study .</brief_summary>
	<brief_title>Extravascular Lung Water Monitoring Combined Ultrasound Bioimpedance Guide Treatment Hemodialysis Patients</brief_title>
	<detailed_description />
	<criteria>patient hemodialysis 3 month , absolute contraindication perform bioimpedance measurement ( amputation , stent , pregnancy , severe ascites ) ultrasound lung comet measurement ( persistent pleuresia , pulmonary fibrosis , pneumectomy ) . Patients metallic joint prosthesis , cardiac pacemaker , decompensated cirrhosis , limb amputation severe condition life expectation &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>bioimpedance</keyword>
	<keyword>overhydration</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>arterial stiffness</keyword>
	<keyword>mortality</keyword>
</DOC>